1. Home
  2. ATRC vs VVX Comparison

ATRC vs VVX Comparison

Compare ATRC & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • VVX
  • Stock Information
  • Founded
  • ATRC 2000
  • VVX 2014
  • Country
  • ATRC United States
  • VVX United States
  • Employees
  • ATRC N/A
  • VVX N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • VVX Diversified Commercial Services
  • Sector
  • ATRC Health Care
  • VVX Consumer Discretionary
  • Exchange
  • ATRC Nasdaq
  • VVX Nasdaq
  • Market Cap
  • ATRC 1.7B
  • VVX 1.8B
  • IPO Year
  • ATRC 2005
  • VVX 2014
  • Fundamental
  • Price
  • ATRC $35.83
  • VVX $56.05
  • Analyst Decision
  • ATRC Strong Buy
  • VVX Buy
  • Analyst Count
  • ATRC 10
  • VVX 10
  • Target Price
  • ATRC $49.60
  • VVX $64.60
  • AVG Volume (30 Days)
  • ATRC 416.8K
  • VVX 344.7K
  • Earning Date
  • ATRC 10-28-2025
  • VVX 11-03-2025
  • Dividend Yield
  • ATRC N/A
  • VVX N/A
  • EPS Growth
  • ATRC N/A
  • VVX N/A
  • EPS
  • ATRC N/A
  • VVX 2.19
  • Revenue
  • ATRC $499,946,000.00
  • VVX $4,333,661,000.00
  • Revenue This Year
  • ATRC $16.32
  • VVX $4.21
  • Revenue Next Year
  • ATRC $12.37
  • VVX $5.48
  • P/E Ratio
  • ATRC N/A
  • VVX $24.86
  • Revenue Growth
  • ATRC 16.28
  • VVX 5.07
  • 52 Week Low
  • ATRC $25.57
  • VVX $41.08
  • 52 Week High
  • ATRC $43.11
  • VVX $69.75
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 50.53
  • VVX 52.04
  • Support Level
  • ATRC $34.57
  • VVX N/A
  • Resistance Level
  • ATRC $38.08
  • VVX $55.58
  • Average True Range (ATR)
  • ATRC 1.46
  • VVX 1.51
  • MACD
  • ATRC -0.24
  • VVX -2.48
  • Stochastic Oscillator
  • ATRC 37.06
  • VVX 95.22

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: